TAIHO ONCOLOGY

Prescription Drugs
Clinical trials: 68No open roles listed
Data updated Nov 20, 2026Full reportReport a mistake

Facts

as of Nov 20, 2026

Choose a country on the map to see corporate head office contact information including address, phone number and website.

Official records
Wikidata Q30269295
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

Products

Products →

TAIHO ONCOLOGY holds 3 FDA approvals of new drugs and biologics. TAIHO ONCOLOGY has 68 clinical trials on record, 15 under way.

top 6%Web presenceof 133.2M domains by links, Common Crawl
FDA approvals
Lytgobi
New drug (NDA) · NDA214801 · futibatinib · oral
Sep 2022
Inqovi
New drug (NDA) · NDA212576 · cedazuridine, decitabine · oral
Jul 2020
Lonsurf
New drug (NDA) · NDA207981 · tipiracil hydrochloride, trifluridine · oral
Sep 2015
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.

TAIHO ONCOLOGY: 143 research papers in five years.

Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Newsroom

top 6%Web presenceof 133.2M domains by links, Common Crawl
Sources: the outlets named on each headline, each story once